Verition Fund Management LLC Axsome Therapeutics, Inc. Transaction History

Verition Fund Management LLC

  • $13 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$58.39 - $75.0 $543,961 - $698,700
9,316 New
9,316 $574,000
Q3 2022

Nov 14, 2022
BUY
$36.06 - $69.85 $394,604 - $764,368
10,943 New
10,943 $488,000
Q2 2020

Aug 14, 2020
SELL
$49.87 - $98.69 $1.66 Million - $3.28 Million
-33,200 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$41.2 - $101.31 $1.37 Million - $3.36 Million
33,200 New
33,200 $1.95 Million

Others Institutions Holding AXSM

# of Institutions
290
Shares Held
37.1M
Call Options Held
401K
Put Options Held
464K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.38B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email